Dr. Yutaka Tomizawa, MD
- Medicare services, 2024
- 61
- Medicare patients, 2024
- 92
- Part D claims, 2024
- 140
- Publications
- 46
- MIPS score, 2024
- 94
- Practice address
- 325 9th Avenue, Seattle, WA 98104
- Practice phone
- Call (206) 744-9535
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Tomizawa's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Yutaka Tomizawa is a gastroenterologist in Seattle, Washington
Dr. Tomizawa practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.
Dr. Tomizawa's NPI, 1386962900, was assigned on May 6, 2010. Dr. Tomizawa holds Washington license MD60768309.
- NPI
- 1386962900NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4789987942
- NPI enumeration date
- May 6, 2010
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (206) 744-9535
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Yutaka Tomizawa practices at Harborview Medical Center in Seattle, Washington
Dr. Tomizawa's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.
- Harborview Medical Center325 9th Avenue, Seattle, WA 98104 · King CountyPhone(206) 744-9535
Source: Dmand AI Affiliation Data
Dr. Yutaka Tomizawa is affiliated with 2 sites of care and 1 medical group
Dr. Tomizawa's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Tomizawa to 1 more hospital, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Yutaka Tomizawa's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tomizawa practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Harborview Medical Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Washington and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Yutaka Tomizawa is one of 434 gastroenterologists in Washington
Gastroenterology is Dr. Tomizawa's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Tomizawa is licensed in Washington.
Specialties and state licenses
- Gastroenterology, WashingtonPrimary
Gastroenterologists near Dr. Tomizawa
Counts of gastroenterologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Yutaka Tomizawa billed Medicare for 61 services in 2024
CMS data shows 61 Medicare services from Dr. Tomizawa across 3 procedure codes in 2024, for 92 Medicare patients. Medicare paid $7,756 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Tomizawa's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Surgery
- 2023: 952024: 6136%
- Office and hospital visits
- 2023: 122024: 0100%
Dr. Tomizawa compared with the Washington median for gastroenterologists, 2024
- Dr. Tomizawa
- Washington median
- Medicare services
- 61vs 35683% below
- Medicare patients
- 92vs 24462% below
- Part D claims
- 98vs 27264% below
Medians across 433 gastroenterologists in Washington with Dmand AI profiles that report each measure.
Dr. Tomizawa's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Tomizawa?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Tomizawa and other gastroenterologists in Washington.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Yutaka Tomizawa treated 92 Medicare patients in 2024, average age 71
CMS counts 92 Medicare patients who saw Dr. Tomizawa in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Tomizawa's median patient age at 58, with 48% women.
Dr. Tomizawa's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Tomizawa's Medicare patients by sex, 2024
- Women4145%
- Men5155%
Chronic conditions among Dr. Tomizawa's Medicare patients, 2024
- High blood pressure75%
- High cholesterol63%
- Arthritis35%
- Diabetes29%
- Ischemic heart disease27%
- Anxiety24%
- Mood disorders23%
- Atrial fibrillation21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Tomizawa's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 58
Patient panel by sex, all payers
- Women48%
- Men51%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Yutaka Tomizawa wrote 140 Medicare Part D claims in 2024
In 2024, Dr. Tomizawa wrote 140 Medicare Part D claims for 89 patients. 79% of them were for generic drugs. CMS names the drug for 98 of them, across 5 drugs with 11 or more claims each, at $2,178 in total drug cost. In 2023, CMS named 93 claims across 3 drugs.
Dr. Tomizawa's Part D claims by kind of drug, 2024
- Generic111 claims79%
- Brand-name29 claims21%
Dr. Tomizawa's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 932024: 985%
Drugs named by CMS: 5 in 2024, 3 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Yutaka Tomizawa scored 94 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Tomizawa for performance year 2024, reported through an alternative payment model (APM). Dr. Tomizawa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tomizawa as offering telehealth. CMS counts 136 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Tomizawa, more than 83% of the clinicians it reports for that procedure.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Tomizawa's MIPS scores, performance year 2024
- 94of 100Final score
- 74.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Where Dr. Tomizawa ranks in Medicare procedure volume
- Upper gastrointestinal (GI) endoscopy for acid reflux
- 83rd percentile136 procedures
- Colonoscopy
- 49th percentile22 procedures
CMS ranks each clinician against every clinician it reports for the same procedure category.
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Yutaka Tomizawa has 46 publications on record
Dmand AI links 46 papers to Dr. Tomizawa, published from 2011 to 2024. 2018 was the busiest year, with 6. The most frequent topics are Colonoscopy, Endoscopic Mucosal Resection and Tomography, X-Ray Computed. Dr. Tomizawa has published most often in Gastroenterology. Dr. Tomizawa's most frequent co-authors are Peter V. Draganov, MD, Atsushi Sakuraba, MD and Adam E. Sohnen.
Dr. Tomizawa's papers by year, 2015 to 2024
Topics Dr. Tomizawa writes about most
- Colonoscopy
- Endoscopic Mucosal Resection
- Tomography, X-Ray Computed
- Barrett Esophagus
- Biopsy
- Colorectal Neoplasms
- Duodenal Neoplasms
- Early Detection of Cancer
Dr. Tomizawa's most frequent co-authors
- Peter V. Draganov, MD5 shared papers
- Atsushi Sakuraba, MD5 shared papers
- Adam E. Sohnen4 shared papers
Recent publications by Dr. Tomizawa
Gastrointest Endosc
Gastrointest Endosc
See who Dr. Tomizawa researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Tomizawa works with, so you can find a warm path to the right gastroenterologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Yutaka Tomizawa received $40,038 in industry payments from 2017 to 2025
CMS Open Payments shows 36 general payments to Dr. Tomizawa from 7 drug and device companies from 2017 to 2025. Grants make up the largest share, 62% of the total. Boston Scientific Corporation paid the most, $37,875. It also lists 1 research payment totaling $800 in 2021.
General payments to Dr. Tomizawa by program year, 2017 to 2025
General payments to Dr. Tomizawa by kind, 2017 to 2025
- Grants$25,00062%
- Speaker and faculty fees$10,75027%
- Food and beverage$2,2226%
- Travel and lodging$1,9985%
- Education$680%
Companies that paid Dr. Tomizawa the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Yutaka Tomizawa's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Yutaka Tomizawa
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Yutaka Tomizawa's NPI number?
Dr. Yutaka Tomizawa's NPI number is 1386962900. It was assigned on May 6, 2010, and it is active in the NPI Registry.
What kind of doctor is Dr. Yutaka Tomizawa?
Dr. Yutaka Tomizawa is a gastroenterologist in Seattle, Washington. The primary specialty in the NPI Registry is Gastroenterology Physician (taxonomy code 207RG0100X).
Where does Dr. Yutaka Tomizawa practice?
Dr. Tomizawa practices at 325 9th Avenue, Seattle, WA 98104. Dr. Tomizawa's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Dmand AI also links Dr. Tomizawa to 1 hospital.
What is Dr. Yutaka Tomizawa's office phone number?
The practice phone on file for Dr. Tomizawa is (206) 744-9535.
What is Dr. Yutaka Tomizawa's medical license number?
Dr. Tomizawa holds Washington license MD60768309.
Which hospitals is Dr. Yutaka Tomizawa affiliated with?
Dr. Tomizawa practices at Harborview Medical Center in Seattle, Washington. Dmand AI links Dr. Tomizawa to 1 more hospital.
What medical group is Dr. Yutaka Tomizawa part of?
Dr. Tomizawa is linked to UW Physicians.
Does Dr. Yutaka Tomizawa accept Medicare?
Yes. CMS data shows Dr. Tomizawa billed Medicare for 61 services in 2024, and Dr. Tomizawa accepts Medicare assignment.
Does Dr. Yutaka Tomizawa offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Tomizawa as offering telehealth services.
What is Dr. Yutaka Tomizawa's MIPS score?
Dr. Tomizawa's MIPS final score for performance year 2024 is 94 out of 100, reported through an alternative payment model (APM).
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Yutaka Tomizawa see?
CMS counts 92 Medicare patients who saw Dr. Tomizawa in 2024, with an average age of 71.
What services does Dr. Yutaka Tomizawa bill to Medicare?
In 2024, Dr. Tomizawa's most billed Medicare services were surgery: digestive system (43239), surgery: digestive system (45385) and surgery: digestive system (45380).
What drugs does Dr. Yutaka Tomizawa prescribe most?
In 2024 Medicare Part D data, Dr. Tomizawa's most prescribed drugs by claims were Omeprazole, Gavilyte-G and Peg-3350 And Electrolytes.
Has Dr. Yutaka Tomizawa received payments from drug or device companies?
CMS Open Payments shows $40,038 in general payments to Dr. Tomizawa from 7 companies from 2017 to 2025. The largest total came from Boston Scientific Corporation.
How long has Dr. Yutaka Tomizawa been practicing?
Dr. Tomizawa graduated from medical school in 2002, 24 years ago.
Does Dr. Yutaka Tomizawa do research?
Dmand AI links 46 publications to Dr. Tomizawa, published from 2011 to 2024.
Who does Dr. Yutaka Tomizawa publish with?
Dr. Tomizawa's most frequent co-authors are Peter V. Draganov, MD (5 shared papers), Atsushi Sakuraba, MD (5 shared papers) and Adam E. Sohnen (4 shared papers).
Selling to gastroenterology practices?
See gastroenterologists in Washington by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card